Literature DB >> 26168093

Defensive Functioning Among Women With Breast Cancer and Matched Community Controls.

J Christopher Perry, Jesse Metzger, John J Sigal.   

Abstract

OBJECTIVE: The general theory of defense mechanisms posits that stress is associated with using defenses lower on the hierarchy of defensive adaptation. Some have observed that individuals with cancer use certain defenses, such as repression, denial, and immature defenses. This cross-sectional study examined four hypotheses about defensive functioning in a sample of women who are mothers with a recent history of breast cancer (BC), compared to a matched sample of healthy mothers in the community.
METHOD: We rated defenses from interview transcripts about interpersonal vignettes, using the Defense Mechanism Rating Scales quantitative method. Measures of symptoms and functioning were also gathered.
RESULTS: The BC group displayed lower (z = 5.39, df = 1,231, p < .0001) overall defensive functioning than controls: 5.32 [95% CI: 5.13 to 5.51] versus 5.63 [95% CI: 5.50 to 5.76], which is equivalent to a medium effect size (0.62). Compared to controls, the BC group displayed more denial, idealization, displacement, isolation of affect, and splitting of others' images; conversely, they used less altruism, anticipation, intellectualization, and undoing. Controls used a mixture of high adaptive (35.5%), neurotic (43.0%), and immature defenses (21.4%). In contrast, the BC group used fewer high adaptive (30.7%) and neurotic (38.8%) and more immature defenses (30.5%). Both groups scored in relatively healthy ranges on other measures. Correlations with other measures supported the hierarchy of defense adaptiveness.
CONCLUSIONS: The relationships among stress, defensive functioning, and adaptation were largely as predicted. Future studies should examine defenses in the process of seeking care, diagnosis, and treatment response for breast cancer.

Entities:  

Mesh:

Year:  2015        PMID: 26168093     DOI: 10.1080/00332747.2015.1051445

Source DB:  PubMed          Journal:  Psychiatry        ISSN: 0033-2747            Impact factor:   2.458


  7 in total

1.  Coping in Patients With Incurable Lung and Gastrointestinal Cancers: A Validation Study of the Brief COPE.

Authors:  Teresa L Hagan; Joel N Fishbein; Ryan D Nipp; Jamie M Jacobs; Lara Traeger; Kelly E Irwin; William F Pirl; Joseph A Greer; Elyse R Park; Vicki A Jackson; Jennifer S Temel
Journal:  J Pain Symptom Manage       Date:  2016-10-08       Impact factor: 3.612

2.  Defense Profiles in Adaptation Process to Sport Competition and Their Relationships with Coping, Stress and Control.

Authors:  Michel Nicolas; Guillaume Martinent; Martin Drapeau; Khadija Chahraoui; Philippe Vacher; Yves de Roten
Journal:  Front Psychol       Date:  2017-12-19

3.  Psychological Factors as Determinants of Chronic Conditions: Clinical and Psychodynamic Advances.

Authors:  Ciro Conversano; Mariagrazia Di Giuseppe
Journal:  Front Psychol       Date:  2021-01-28

4.  Retrospective Analyses of Psychological Distress and Defense Style Among Cancer Patients.

Authors:  Ciro Conversano; Mariagrazia Di Giuseppe; Mario Miccoli; Rebecca Ciacchini; Annarita Di Silvestre; Rosa Lo Sterzo; Angelo Gemignani; Graziella Orrù
Journal:  Clin Neuropsychiatry       Date:  2020-08

5.  Psychological Impact of Coronavirus Disease 2019 Among Italians During the First Week of Lockdown.

Authors:  Mariagrazia Di Giuseppe; Sigal Zilcha-Mano; Tracy A Prout; John Christopher Perry; Graziella Orrù; Ciro Conversano
Journal:  Front Psychiatry       Date:  2020-09-30       Impact factor: 4.157

6.  The Role of Suppression and the Maintenance of Euthymia in Clinical Settings.

Authors:  Emanuele Maria Merlo; Anca Pantea Stoian; Ion G Motofei; Salvatore Settineri
Journal:  Front Psychol       Date:  2021-05-20

7.  Defense Mechanisms and Repressive Coping Among Male Breast Cancer Patients.

Authors:  Rainer Weber; Johannes C Ehrenthal; Evamarie Brock-Midding; Sarah Halbach; Rachel Würstlein; Christoph Kowalski; Nicole Ernstmann
Journal:  Front Psychiatry       Date:  2021-12-10       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.